Send me a link:

*Text messaging rates may apply.

 Dow Up 0.18% Nasdaq Up 0.05%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
4.63 Down 0.14(3.04%) 2:02PM EDT - Nasdaq Real Time Price
Prev Close:4.77
Open:4.76
Bid:4.62 x 10100
Ask:4.63 x 12400
1y Target Est:7.83
Beta:-2.36
Earnings Date:Jul 28 - Aug 1 (Est.)
Day's Range:4.60 - 4.79
52wk Range:4.05 - 7.97
Volume:3,913,412
Avg Vol (3m):5,373,450
Market Cap:1.02B
P/E (ttm):N/A
EPS (ttm):-0.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARNADown 3.04%1.02B
GSKDown 0.93%115.66B
OREXDown 1.89%603.74M
RHHBYDown 0.23%250.19B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.21
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.43
Quarterly EPS Est (Jun-14) :-0.11
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):0.09

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback